-
公开(公告)号:US20140128439A1
公开(公告)日:2014-05-08
申请号:US13961848
申请日:2013-08-07
申请人: Metabolex, Inc.
IPC分类号: C07C59/68 , A61K31/426 , A61K31/192 , C07C233/47 , A61K31/216
CPC分类号: A61K31/216 , A61K31/192 , A61K31/426 , C07C59/68 , C07C233/47
摘要: Methods of treating gout flares comprising administering a composition comprising a first urate-lowering agent are disclosed. In some aspects, the first urate-lowering agent is (−)-halofenate, (−)-halofenic acid, or a pharmaceutically acceptable salt thereof. Other aspects provide for methods of reducing the number, duration, frequency or intensity of gout flares experienced by a subject.